Tag Archives: Atypical Antipsychotics

Reducing Antipsychotic Prescribing for BPSD (BMJ / JAMA)

Posted on November 6, 2014 by Dementia and Elderly Care News (an online adjunct to Dementia and Elderly Care: the Latest Evidence)

Summary This BMJ “Change page” article discusses the potential harms associated with use of antipsychotics in people with dementia, and covers guidelines recommending restrictions in their use. Risperidone is the antipsychotic recommended for use in the treatment of aggression associated … Continue reading →

Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, Standards, UK | Tagged Adverse Effects, Aggression, Aggressive Behaviour, Alternatives to Antipsychotics, Antipsychotic Drugs, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics Limitation in Dementia, Antipsychotics Side Effects, Antipsychotics-Related Mortality Risks, Antipsychotics: Neuroleptic Sensitivity, Atypical Antipsychotics, Behavioural and Psychological Symptoms of Dementia (BPSD), BMJ, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Brief Psychosocial Treatment, British Medical Journal (BMJ), Campbell Institute (CAMH): University of Toronto, CitAD Research Group, Citalopram for Agitation in Alzheimer's Disease: CitAD Trial, Clinical Biotechnology Research Institute: Roper St Francis Healthcare (Charleston: South Carolina), College of Physicians and Surgeons of Columbia University, DART-AD: Dementia Antipsychotic Withdrawal Trial (DART-AD), Dementia Antipsychotic Withdrawal Trial (DART-AD), Discontinuation of Antipsychotics, Effect of Citalopram on Agitation in Alzheimer Disease (CitAD Randomized Clinical Trial), Hotchkiss Brain Institute: University of Calgary, Inappropriate Use of Antipsychotics in Dementia, JAMA, Johns Hopkins Bayview and Johns Hopkins School of Medicine, Johns Hopkins Bloomberg School of Public Health: Baltimore, Kings College London, National Institute for Health Research (NIHR): Mental Health Biomedical Research Centre and Dementia Unit, NEST Approach, Neuroleptic Discontinuation, New York State Psychiatric Institute, Patients’ Needs and the Environment Stimulation and Techniques (NEST), Perelman School of Medicine: University of Pennsylvania, Personalised Social Interaction, Potential Harms of Antipsychotic Use, Prescribing Anti-Psychotic Drugs to People with Dementia, Reducing Agitation and Distress, Reducing Antipsychotic Medication in Care Homes, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, Reducing Violence and Aggression, Risperidone, Seattle Protocols, Simulated Presence Therapy, South London and Maudsley NHS Foundation Trust, Stanford University School of Medicine, United States, University of Calgary, University of Manchester, University of Pennsylvania, University of Rochester School of Medicine and Dentistry, University of Southern California Keck School of Medicine, University of Toronto, Violence and Aggression, Wolfson Centre for Age-Related Diseases: King’s College London | Leave a comment

Reducing Antipsychotic Prescriptions for Dementia in Primary Care (HSJ / NHS London)

Posted on September 26, 2014 by Dementia and Elderly Care News (an online adjunct to Dementia and Elderly Care: the Latest Evidence)

Summary The Dementia and Prescribing Antipsychotic Project, run by London-based CCGs, helped to reduce prescribing levels by between 48% and 77%. The project aimed to raise awareness of the risks of antipsychotic prescribing for behavioural and psychological symptoms in dementia. … Continue reading →

Posted in Antipsychotics, Commissioning, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, NHS, Non-Pharmacological Treatments, Patient Care Pathway, Patient Information, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, Standards, UK, Universal Interest | Tagged Antipsychotic Drugs, Antipsychotic Prescribing in Care Homes, Antipsychotic Prescribing in Nursing Homes, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics Limitation in Dementia, Antipsychotics Side Effects, Antipsychotics-Related Mortality Risks, Antipsychotics: Neuroleptic Sensitivity, Atypical Antipsychotics, Behavioural and Psychological Symptoms of Dementia (BPSD), Bexley, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Bromley, Care Homes, CCGs, Clinical Commissioning Groups (CCGs), Community Care, Community Care Services, Community Pharmacists, Croydon, Dementia and Prescribing Antipsychotic Project, Differemtial Antipsychotic-Related Mortality Risks, Differential Risk of Death (Antipsychotic Drugs), Distressed Behaviour, East and South East Specialist Pharmacy Services, General Practice, GP Clusters, GPs, Guideline on Supporting People with Dementia and Their Carers in Health and Social Care, Guys and St Thomas Foundation Trust, Health Service Journal (HSJ), Home and Community Care Services, HSJ, Inappropriate Use of Antipsychotics in Dementia, Integrated Care Services, Integrated Commissioning, Integration of Pharmacy Into Community Care, Local Commissioning, London Antipsychotics Audit and Reduction Exercise in Primary Care, London GP Practice Audit of Antipsychotic Prescribing to People With Dementia, London Primary Care, Managing Medicines in Care Homes, Managing Psychological and Behavioural Distress in People with Dementia, Medicines Management, Medicines Management Audits, Mental Health Pharmacists, NHS London, NHSL Antipsychotic GP Audit, NICE Clinical Guideline 42. Dementia: Supporting People With Dementia And Their Carers In Health And Social Care, NICE–SCIE Guideline on Supporting People with Dementia and Their Carers in Health and Social Care, Pharmacists, Prescribing Anti-Psychotic Drugs to People with Dementia, Primary Care, Psychological Symptoms of Dementia (BPSD), Quality and Outcomes Framework (QOF), Reducing Agitation and Distress, Reducing Antipsychotic Medication in Care Homes, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, Richmond, Supporting People with Dementia and Their Carers in Health and Social Care, Wandsworth | Leave a comment

Pharmacological Treatments for Neuropsychiatric Symptoms in Alzheimer’s Disease (Journal of Neurology Neurosurgery and Psychiatry)

Posted on June 25, 2014 by Dementia and Elderly Care News (an online adjunct to Dementia and Elderly Care: the Latest Evidence)

Summary This systematic review investigates the efficacy and safety of various pharmacological treatments for neuropsychiatric symptoms in Alzheimer’s Disease patients. It concludes that cholinesterase inhibitors (ChEIs) and atypical antipsychotics could improve neuropsychiatric symptoms in these patients, but with poor patient … Continue reading →

Posted in Antipsychotics, Depression, For Doctors (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Pharmacological Treatments, Systematic Reviews | Tagged Adverse Drug Reactions, Adverse Effects, Adverse Events, Antidepressants, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics Limitation in Dementia, Antipsychotics Side Effects, Antipsychotics-Related Mortality Risks, Antipsychotics: Neuroleptic Sensitivity, Atypical Antipsychotics, Behavioural and Psychological Symptoms of Dementia (BPSD), Benzodiazepines, Benzodiazepines for BPSD, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Cerebrovascular Adverse Events, ChEIs: Cholinesterase Inhibitors, China, Cholinesterase Inhibitors, Journal of Neurology Neurosurgery and Psychiatry, Memantine, Mood Stabilisers, Nanjing Medical University, Neuropsychiatric Inventory (NPI), Neuropsychiatric Symptoms in Alzheimer’s Disease, Patient Safety, Pharmacological Treatments for Neuropsychiatric Symptoms in Alzheimer’s Disease, Qingdao Municipal Hospital, Qingdao University, Serious Adverse Events, Shandong Province, Systematic Reviews and Meta-Analyses | Leave a comment

Reducing Antipsychotic Drugs in Care Homes (Nursing Times)

Posted on June 16, 2014 by Dementia and Elderly Care News (an online adjunct to Dementia and Elderly Care: the Latest Evidence)

Summary A recent Nursing Times articles covers the use of antipsychotic drugs for people with dementia living in care homes. It discusses a review by pharmacists which resulted in the use of these drugs being reduced or discontinued. It covers … Continue reading →

Posted in Antipsychotics, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, RCN, Standards, UK, Universal Interest | Tagged Alternatives to Antipsychotic Medication, AntiCholinergic Burden Scale, Anticholinergic Discontinuation, Anticholinergic Drugs, Anticholinergics, Antipsychotic Drugs, Antipsychotic Prescribing in Care Homes, Antipsychotic Prescribing in Nursing Homes, Antipsychotics Side Effects, Antipsychotics-Related Mortality Risks, Atypical Antipsychotics, Behavioural and Psychological Symptoms of Dementia (BPSD), Boots Care Services, Boots UK, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Care Homes, Differemtial Antipsychotic-Related Mortality Risks, Differential Risk of Death (Antipsychotic Drugs), Inappropriate Use of Antipsychotics in Dementia, Managing Medicines in Care Homes, Nursing Times, Quetiapine, Reducing Antipsychotic Drugs in Care Homes, Reducing Antipsychotic Medication in Care Homes, Reducing Inappropriate Use of Antipsychotics in Dementia, School of Pharmacy: University of East Anglia, University of East Anglia | Leave a comment

Mainstream Dementia Pathways Literature (British Psychological Society)

Posted on April 22, 2014 by Dementia and Elderly Care News (an online adjunct to Dementia and Elderly Care: the Latest Evidence)

Summary This document was released last year by the Dementia Work Stream of the Faculty of the Psychology of Older People (FPOP) at the British Psychological Society. It reflects a literature review performed between 2011 and 2012 to find important … Continue reading →

Posted in Alzheimer's Society, Antipsychotics, Commissioning, Dementia Action Alliance, For Researchers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Northern Ireland, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Quick Insights, Royal College of Psychiatrists, SCIE, Scotland, UK, Universal Interest, Wales | Tagged Adult Mental Health Services, Age Discrimination, Age Discrimination in Mental Health, Alternatives to Antipsychotic Drugs, Alternatives to Antipsychotic Medication, Anti-Psychotic Drugs for Dementia, Antipsychotic Drugs, Antipsychotics, Antipsychotics in Elderly People with Dementia, Aromatherapy, Atypical Antipsychotics, Behavioral and Psychological Symptoms of Dementia (BPSD), Behaviour, Behavioural Alternatives to Antipsychotic Drugs, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, British Geriatric Society (BGS), British Psychological Society, British Psychological Society: Faculty of the Psychology of Older People (FPOP), Challenging Behaviour, Clinical Psychology, Commissioning Clinical Psychology Services for Older People, Commissioning Dementia Services, Commissioning Effective Dementia Services, Coping With Behavioural Disorders, Counting the Cost, DCP: Division of Clinical Psychology, Delirious About Dementia (BGS), Dementia Commissioning Pack, Dementia Pathway, Dignity in Dementia, Dr Linda Buettner, Enriched Opportunities Programme (EOP), Extra Care Charitable Trust’s (ECCT) Enriched Opportunities Programme (EOP), FPOP: BPS Faculty of the Psychology of Older People, Functional Analysis-Based Interventions for Challenging Behaviour, Good Practice Compendium, Guidelines for Clinical Psychology Services, Healthcare for London, Improving Patient Care at Home: How to Cope, Inappropriate Prescribing, Jiska Cohen-Mansfield, Liaison Mental Health Services, Life Story Network (LSN), Living Well with Dementia, Managing Psychological and Behavioural Distress in People with Dementia, Music Therapy, Music Therapy for BPSD, National Audit of Dementia Care in Hospitals, National Dementia Strategy, NHS Atlas of Variation, NHS Atlas of Variations in Diagnostic Services, NHS Institute for Innovation and Improvement, Peer Review in Social Protection and Social Inclusion, Policy Innovation and Research, Policy Research Unit, Professor Clive Ballard, Professor Esme Moniz-Cook, Professor Sube Banerjee, PSIGE: Faculty for Old Age Psychology (British Psychological Society: Division of Clinical Psychology), Psychological and Behavioural Distress, Reducing Antipsychotic Medication in Care Homes, Research E-Journal Issue 11 (Scientific Version), Royal College of Speech & Language, Scotland’s National Dementia Strategy, Stepped Care Model of Assessment and Intervention, University of Bradford, University of Bradford Dementia Group, US Department of Veterans Affairs Health Services Research and Development Service, World Alzheimer Report (2012) | Leave a comment

Pharmacotherapies for Sleep Disturbances in Alzheimer’s Disease (Cochrane Database)

Posted on April 17, 2014 by Dementia and Elderly Care News (an online adjunct to Dementia and Elderly Care: the Latest Evidence)

Summary This systematic review investigates the efficacy and adverse effects of drug treatments for sleep disturbances in Alzheimer’s Disease. The authors comment on the lack of evidence to guide drug treatment of sleep problems in Alzheimer’s Disease. Full Text Link … Continue reading →

Posted in For Doctors (mostly), For Researchers (mostly), International, Pharmacological Treatments, Systematic Reviews, UK | Tagged Atypical Antipsychotics, Benzodiazepines, Circadian Disturbances in People with Dementia, Circadian Rhythms, Cochrane Database, Cochrane Database of Systematic Reviews, Daytime Sleepiness, Division of Sleep Medicine: Boston MA, GABAergic Drugs, Hypersomnia, Hypnotic Drugs, Insomnia, Melatonin, National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’sDisease and RelatedDisorders Association (NINCD-ADRDA), Nocturnal Wandering, Non-Benzodiazepine Hypnotics, Oxford Health NHS Foundation Trust, Oxford University, Parasomnia, Pharmacotherapies for Sleep Disturbances in Alzheimer’s Disease, Ramelteon, Rebound Insomnia, Reduced Nocturnal Sleep Time, Rest-Activity and Sleep-Wake Cycles, Sedating Antidepressants, Sleep, Sleep Disturbances, Sleep Disturbances in Alzheimer’s Disease, Sleep Fragmentation, Somnolence, Sundowning, Suprachiasmatic Nuclei (SCN) in the Hypothalamus, Systematic Reviews and Meta-Analyses, Trazodone, Zaleplon, Zolpidem, Zopiclone | Leave a comment

Discontinuation of Antipsychotics in Patients with Dementia (Dementia and Geriatric Cognitive Disorders)

Posted on January 3, 2014 by Dementia and Elderly Care News (an online adjunct to Dementia and Elderly Care: the Latest Evidence)

Summary The authors performed a systematic review and meta-analysis of randomised controlled studies comparing the outcomes of antipsychotics discontinuation (versus their continuation) in people with dementia. Changes to the severity of behavioural and psychological symptoms of dementia (BPSD) was the … Continue reading →

Tag Archives: Atypical Antipsychotics

Pharmacotherapies for Sleep Disturbances in Alzheimer’s Disease (Cochrane Database)

Recent Posts

Archives

Categories

Recommended Sites

Follow “Dementia and Elderly Care News”